3 New Strong Buy Ratings from Top-Rated Analysts: 06/17/2025

Hey, we started your stock research homework for you! Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:

• TTM Technologies (TTMI) provides an essential service — and its stock price could mirror continued consumer demand 
• Niagen Bioscience (NAGE) has already rallied 148% — is there more to come?
• Why Tutor Perini (TPC) boasts such impressive growth prospects

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

A note from our sponsors...
Free Today: Top 7 Nuclear Stocks for 2025  

The nuclear surge is real - 40%+ gains in 2024 and expected to shoot higher in 2025. Our 7 Top Nuclear Stocks to Buy Now report, FREE for a limited time, delivers the tickers to own now. These stocks were specifically vetted with rigorous analysis, and they all have serious upside potential...  

Get your report before it's pay-only!  

1. Niagen Bioscience (NASDAQ: NAGE)

Niagen Bioscience has patented a form of nicotinamide riboside (NR), which has recently demonstrated promising results in the treatment of Werner syndrome in a phase 1 trial. NAGE has already rallied by 148% on a year-to-date (YTD) basis, and both Wall Street researchers and our system have it pegged as a likely performer going forward.

Zen Rating: B (Buy) — see full analysis >  

Recent Price: $13.75 — get current quote > 

Max 1-year forecast: $23.00 

Why we’re watching:

• At present, 4 Wall Street analysts track NAGE and issue ratings for it. The stock currently has 3 Strong Buy ratings and 1 Buy rating. See the ratings
• Roth Capital equity researcher Sean McGowan (a top 26% rated analyst) recently reiterated a Strong Buy rating, and hiked his price target for the stock from $10 to a Street-high $23.
• McGowan hiked their price target on the heels of the 2025/06/09 announcement of positive results of the first clinical study demonstrating the safety and efficacy of Niagen Bioscience’s patented nicotinamide riboside (NR) ingredient, Niagen®, in individuals with Werner syndrome (WS), a rare genetic disorder giving rise to rapid aging and premature mortality.
• The analyst backgrounded that "the stock has been very strong over the last year and continues to offer significant upside potential from the expansion of its addressable markets pending the outcome of a number of trials and studies currently in process.
• Also relevant, McGowan said, were the continued strong growth in sales of TruNiagen, Niagen Bioscience's core product, the company's immunity from the impact of tariffs, and encouraging progress regarding several new initiatives, including Niagen Plus, which began rolling out to clinics late last year.
• Niagen Bioscience stock ranks in the top 6% of the equities that we track based on a holistic analysis of 115 proprietary factors, giving it a Zen Rating of B, which corresponds to an average annual return of 19.88%.
• Due to strong earnings per share (EPS) growth, NAGE ranks in the top 12% of stocks in terms of Growth.
• NAGE’s margin growth (from -4.2% to +13.1% within the past year), as well as a low level of leverage (debt-to-equity ratio of 0.47x), have secured it a spot in the top 3% of equities when it comes to Financials. (See all 7 Zen Component Grades here >)

2. Tutor Perini (NYSE: TPC)

Tutor Perini is a construction business that focuses on public works — think highways, tunnels, harbors, bridges, mass transit systems, and the like. Thus far, TPC has gone under the radar — but it maintains a record $19.4 billion backlog, and rates quite highly according to our system when it comes to Growth. 

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $40.56 — get current quote > 

Max 1-year forecast: $50.00 

Why we’re watching:

• TPC hasn’t attracted a lot of attention thus far. Only 2 analysts issue ratings for the stock — and both have given it a Strong Buy rating. See the ratings
• The average price target for Tutor Perini shares works out to $45.50, which implies a 12.18% upside.
• As it currently stands, the most up-to-date coverage comes from B. Riley Securities researcher Liam Burke, who doubled down on a Strong Buy rating and increased his price target on the stock from $40 to a Street-high $50. 
• Factors making Tutor Perini stock an attractive heavy civil infrastructure sector investment and "excellent" value, according to Burke, include a record backlog, better growth outlook, growing operating margins, and a stronger balance sheet.
• The analyst predicted the company's profitability profile would improve by the end of 2025 and that operating profit growth would continue in 2026.
• Tutor Perini is currently the 3rd highest-rated stock in the Engineering & Construction industry, which has an Industry Rating of A.
• TPC ranks in the top 2% of the more than 4,600 equities that we track based on a big-picture analysis of 115 proprietary factors, giving it a Zen Rating of A.
• Positive analyst coverage and a significant degree of insider buying have combined to give Tutor Perini a Sentiment Component Grade rating in the 95th percentile.
• However, the stock’s strongest suit is Growth — where it ranks in the top 2%. (See all 7 Zen Component Grades here >)

3. TTM Technologies (NASDAQ: TTMI) 

This pick is firmly in the behind-the-scenes category. TTM Technologies is one of the largest producers of printed circuit boards (PCBs) in North America. These components are essential for…basically everything, from microwaves and clocks to smartphones and MRI machines. An eminent Wall Street firm recently had a meeting with management — and one of their best analysts seems to have walked away quite bullish.

Zen Rating: A (Strong Buy) — see full analysis >  

Recent Price: $35.70 — get current quote > 

Max 1-year forecast: $41.00 

Why we’re watching:

• TTMI is covered by 4 stock market researchers, and currently has 3 Strong Buy ratings and 1 Buy rating. See the ratings
• William Stein of Truist Securities (a top 1% rated analyst) maintained a Strong Buy rating on TTM Technologies on June 9, and hiked his price target from $36 to a Street-high $41.
• Stein reported that they hosted investor meetings with TTM Technologies' management and that takeaways catalyzed their price target hike.
• The analyst said they were "pleasantly surprised" by the level of confidence displayed regarding idiosyncratic items, such as possible upside from ramping the Penang facility, the possibilities in Syracuse, and TTM's exposure to AI.
• TTMI is the 4th highest rated stock in the Electronic Component industry, which has an Industry Rating of A.
• TTM Technologies stock ranks in the 96th percentile of the more than 4,600 equities that we track, giving it a Zen Rating of A. Stocks with this distinction have provided an average annual return of 32.52% since the early 2000s.
• In terms of its Growth Component Grade rating, the stock ranks in the top 10%. It also ranks in the top 8% and 7%, respectively, when it comes to Safety and Momentum.
• However, Sentiment is TTMI’s strongest Component Grade rating, as it ranks in the top 4% of the stocks we track in this regard. (See all 7 Zen Component Grades here >)

What to Do Next?

• 9 Special Stock Lists You Need Now >
• See All “A” Rated Stocks with +32.52% Average Annual Return >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.